View in EDS HTML Full Text PDF Full Text

Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis.

Saved in:
Bibliographic Details
Title: Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis.
Authors: Mohamed, Mohamed‐Eslam F.1 (AUTHOR) mohamed‐eslam.mohamed@abbvie.com, Qian, Yuli1 (AUTHOR), D'Cunha, Ronilda1 (AUTHOR), Sligh, Teresa2 (AUTHOR), Ferris, Laura K.3 (AUTHOR), Eldred, Ann4 (AUTHOR), Levy, Gweneth F.5 (AUTHOR), Hao, Shuai6 (AUTHOR), Gannu, Shashikanth7 (AUTHOR), Rizzo, David G.7 (AUTHOR), Liu, Wei1 (AUTHOR), Jazayeri, Sasha8 (AUTHOR), Sofen, Howard9 (AUTHOR), Carcereri De Prati, Roberto10 (AUTHOR)
Source: CTS: Clinical & Translational Science. Jan2024, Vol. 17 Issue 1, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17528054
DOI:10.1111/cts.13682